Literature DB >> 8555186

Active site mutation of the C3-like ADP-ribosyltransferase from Clostridium limosum--analysis of glutamic acid 174.

J Böhmer1, M Jung, P Sehr, G Fritz, M Popoff, I Just, K Aktories.   

Abstract

Clostridium limosum ADP-ribosyltransferase modifies low molecular mass GTP-binding proteins of the Rho subtype family. Here we cloned and sequenced the gene of the transferase and expressed it in Escherichia coli. The gene encodes a protein of 250 amino acids (M(r) = 27,840), with a putative signal peptide of 45 amino acids, that shows about 60-65% identity with C3 transferases from Clostridium botulinum. The mature C. limosum transferase was expressed as a maltose-binding fusion protein in E. coli and purified to apparent homogeneity. To study the functional role of Glu174 of C. limosum transferase, which was recently photoaffinity-labeled with [carbonyl-14C]NAD [Jung, M., et al. (1993) J. Biol. Chem. 268, 23215-23218], two mutants E174D and E174Q were constructed by a polymerase chain reaction-based system. The E174D and E174Q mutants showed a dramatic decrease in kcat, but no major changes in Km,NAD. Furthermore, replacement of Glu174 by aspartic acid and glutamine largely reduced and completely blocked UV-induced incorporation of [carbonyl-14C]NAD into the transferase. The data indicate that Glu174 is an active site residue of C. limosum transferase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8555186     DOI: 10.1021/bi951784+

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Regulation of somatodendritic GABAA receptor channels in rat hippocampal neurons: evidence for a role of the small GTPase Rac1.

Authors:  D K Meyer; C Olenik; F Hofmann; H Barth; J Leemhuis; I Brünig; K Aktories; W Nörenberg
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

Review 2.  C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins.

Authors:  Martin Vogelsgesang; Alexander Pautsch; Klaus Aktories
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-12-05       Impact factor: 3.000

3.  Structural basis for the NAD-hydrolysis mechanism and the ARTT-loop plasticity of C3 exoenzymes.

Authors:  Julie Ménétrey; Gilles Flatau; Patrice Boquet; André Ménez; Enrico A Stura
Journal:  Protein Sci       Date:  2008-03-27       Impact factor: 6.725

4.  C3larvin toxin, an ADP-ribosyltransferase from Paenibacillus larvae.

Authors:  Daniel Krska; Ravikiran Ravulapalli; Robert J Fieldhouse; Miguel R Lugo; A Rod Merrill
Journal:  J Biol Chem       Date:  2014-12-04       Impact factor: 5.157

Review 5.  Bacterial factors exploit eukaryotic Rho GTPase signaling cascades to promote invasion and proliferation within their host.

Authors:  Michel R Popoff
Journal:  Small GTPases       Date:  2014-05-08

6.  IcmQ in the Type 4b secretion system contains an NAD+ binding domain.

Authors:  Jeremiah D Farelli; James C Gumbart; Ildikó V Akey; Andrew Hempstead; Whitney Amyot; James F Head; C James McKnight; Ralph R Isberg; Christopher W Akey
Journal:  Structure       Date:  2013-07-11       Impact factor: 5.006

7.  Molecular and biological characterization of Streptococcal SpyA-mediated ADP-ribosylation of intermediate filament protein vimentin.

Authors:  Laura M Icenogle; Shawna M Hengel; Lisette H Coye; Amber Streifel; Carleen M Collins; David R Goodlett; Steve L Moseley
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

8.  The N-terminal part of the enzyme component (C2I) of the binary Clostridium botulinum C2 toxin interacts with the binding component C2II and functions as a carrier system for a Rho ADP-ribosylating C3-like fusion toxin.

Authors:  H Barth; F Hofmann; C Olenik; I Just; K Aktories
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

9.  A negative modulatory role for rho and rho-associated kinase signaling in delamination of neural crest cells.

Authors:  Maya Groysman; Irit Shoval; Chaya Kalcheim
Journal:  Neural Dev       Date:  2008-10-22       Impact factor: 3.842

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.